Insurtechs globally secured $1.4 billion in funding across 69 deals throughout the second quarter of the year, down 2% from Q1, according to a report from Willis Towers Watson and CB Insights. However, year-over-year (YoY) funding increased 273%. Forty-two percent of all insurtech deals this quarter went to startups in the US. Here's what it means: While big insurtech players enjoyed large funding rounds, investments in smaller players declined. The bigger picture: A small number of large players accounting for a majority of funding is a trend we've seen in other fintech areas as well, and it could point to a more mature market. Interested in getting the full story? Here are three ways to get access:
Insurtech investment grew 273% YoY in Q2 with funding rounds at Lemonade, Collective Health, PolicyBazaar and Shuidi Huzhu raising a combined $802m, over half the total $1.4bn raised in US, according to Willis Towers Watson and CB Insights. SoftBank led funding in three of the four top deals. Meanwhile, smaller USs raised $147m in the quarter - the lowest figure since Q3 2017. Fintech investment followed a similar path, with Starling, Monzo, OakNorth and Greensill receiving just over half of the entire fintech funding during H1 2019. The findings suggest that the sectors are maturing.